Comments
Loading...

Franklin Genomic Advancements ETF

HELXBATS
Logo brought to you by Benzinga Data

As of Mar 31, 2025

Number of Stock Holdings
62
Number of Bond Holdings
-
Total Holdings
62
Number of ETFs
-

Franklin Genomic Advancements ETF (BATS:HELX), Top Holdings

Franklin Genomic Advancements ETF (BATS: HELX)

TickerNameShare %
MEDPMedpace Holdings Inc3.52%
VRTXNvaesrtex Pharmaceuticals Inc5.03%
REGNRegeneron Pharmaceuticals, Inc.3.79%
DHRDanaher Corp.5.14%
TMOThermo Fisher Scientific Inc3.38%
KRYSKrystal Biotech Inc5.17%
LLYEli Lilly & Co.3.51%
KRSamsung Biologics Co Ltd3.67%
NTRANatera Inc5.54%
LNAstrazeneca Plc, ADR3.01%
UTHRUnited Therapeutics Corp3.18%
FFBiontech Se2.87%
CTVACorteva  Inc .2.89%

FAQ

Q

How has HELX ETF performed?

A

The HELX ETF is currently trading at $26.83, which represents a -1.51% change. Over the past 52 weeks, the ETF has traded as high as $33.98 and as low as $23.74.

Q

What is the expense ratio for HELX?

A

The expense ratio of HELX is 0.5%. This represents the annual fee that all funds or ETFs charge their shareholders.

Q

What is the Assets Under Management (AUM) for HELX?

A

The total Assets Under Management (AUM) for HELX is 10.90M. This represents the total market value of the assets managed by the ETF.

Q

What is the investment style for HELX?

A

HELX follows a Mid Cap Growth investment style.

Q

What are the top holdings for HELX?

A

The top holdings of HELX include: MEDP (3.52%), VRTX (5.03%), REGN (3.79%), DHR (5.14%), TMO (3.38%). These represent the largest positions in the ETF's portfolio.

Q

What is the average daily trading volume for HELX?

A

Average daily volume data for HELX is currently not available.